TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
1 hedge funds and large institutions have $324K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
130% more capital invested
Capital invested by funds: $141K → $324K (+$183K)
67% less funds holding
Funds holding: 3 → 1 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$639K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Legal & General Group
London,
United Kingdom
|
-$58K |
| 2 |
Renaissance Technologies
New York
|
-$41K |
| 3 |
VF
Virtu Financial
New York
|
-$35K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$4K |
| 5 |
MFGM
Marshall Financial Group (Maryland)
Hunt Valley,
Maryland
|
-$3K |
TCBP Hedge Fund Activity: Q4 2022 in Review
1 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q4 2022, worth a combined $324K — up 130% from $141K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TCBP and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $639K. The largest seller was Legal & General Group, exiting entirely with an estimated $58K sold.
- 1 institutional investor held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q4 2022, down from 3 in Q3 2022.
- Funds reported $324K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q4 2022, up 130% quarter-over-quarter.
- 1 fund opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q4 2022 and 3 closed out, a net change of -2 holders.
- The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q4 2022 was Armistice Capital, an estimated $639K added.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q4 2022 was Legal & General Group, an estimated $58K sold.
Based on aggregated 13F filings for Q4 2022.